Serum GFA Identified as a Biomarker for NMOSD, sNfL as a Predictor of Poor Post-Attack Outcomes
March 12, 2022 A systematic literature review of randomized controlled trials in neuromyelitis optica spectrum disorder was performed, with 7…
NMOSD PATIENTS MAY BE HIDDEN WITHIN THE MS POPULATION
NMO vs MS – Click: https://bit.ly/3tfnPZS An accurate diagnosis of NMOSD is critical, as patients with NMOSD have been misdiagnosed with MS1 Differential…
Stuart Schlossman
What is: Neuromyelitis Optica Spectrum Disorder (NMOSD / NMO)
Synonyms of Neuromyelitis Optica Spectrum Disorder (Asian, Japanese) opticospinal MS Devic disease Devic syndrome optic neuromyelitis opticomyelitis NMOSD Subdivisions of…
Stuart Schlossman
Eculizumab Shows Better Prolonging of Time to NMOSD Relapse Than Other Treatments
October 17, 2021 – Marco Meglio An indirect comparison study evaluated relative treatment effects of eculizumab (Soliris; Alexion), inebilizumab (Uplizna; Horizon),…
Stuart Schlossman
The Status of NMOSD Patient Education and the Development Pipeline
August 28, 2021 – Matt Hoffman Bruce Cree, MD, PhD, clinical research director of the UCSF Multiple Sclerosis Center, provided…
Stuart Schlossman
Neuromyelitis Optica ( NMO) vs. Multiple Sclerosis (MS)
NMO and MS – The Key Differences In the past, Neuromyelitis Optica (NMO) was considered to be a severe variant of multiple…
Stuart Schlossman
B-Cell Depletion May Indicate Reduced COVID-19 Antibody Response Among Patients With MS
New research demonstrates that patients with multiple sclerosis (MS) who were asymptomatic for COVID-19 had lower antibody levels against…
Stuart Schlossman
Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population
Abstract Neuromyelitis Optica (NMO) is an autoimmune disease with a higher prevalence in non-European populations. Because the Mexican population…
Stuart Schlossman
New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expanding Neuroscience Portfolio (MS and NMOD information in this article)
Wednesday, Apr 7, 2021 Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type…
Stuart Schlossman
What’s the Difference Between Neuromyelitis Optica and MS?
Two nerve conditions Multiple sclerosis (MS) is a disease in which the body’s immune system attacks myelin, the outside layer of nerve cells.…
Stuart Schlossman
